Correlation Between Kuang Chi and Cabio Biotech

Can any of the company-specific risk be diversified away by investing in both Kuang Chi and Cabio Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Kuang Chi and Cabio Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Kuang Chi Technologies and Cabio Biotech Wuhan, you can compare the effects of market volatilities on Kuang Chi and Cabio Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Kuang Chi with a short position of Cabio Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Kuang Chi and Cabio Biotech.

Diversification Opportunities for Kuang Chi and Cabio Biotech

0.5

Correlation Coefficient

Kuang Chi  Cabio Biotech

Very weak diversification

The 3 months correlation between Kuang and Cabio is 0.5. Overlapping area represents the amount of risk that can be diversified away by holding Kuang Chi Technologies and Cabio Biotech Wuhan in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cabio Biotech Wuhan and Kuang Chi is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Kuang Chi Technologies are associated (or correlated) with Cabio Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cabio Biotech Wuhan has no effect on the direction of Kuang Chi i.e., Kuang Chi and Cabio Biotech go up and down completely randomly.

Pair Corralation between Kuang Chi and Cabio Biotech

Assuming the 90 days trading horizon Kuang Chi Technologies is expected to generate 1.18 times more return on investment than Cabio Biotech. However, Kuang Chi is 1.18 times more volatile than Cabio Biotech Wuhan. It trades about -0.02 of its potential returns per unit of risk. Cabio Biotech Wuhan is currently generating about -0.25 per unit of risk. If you would invest  4,149  in Kuang Chi Technologies on October 8, 2024 and sell it today you would lose (103.00) from holding Kuang Chi Technologies or give up 2.48% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Kuang Chi Technologies  vs.  Cabio Biotech Wuhan

Kuang Chi Technologies

Risk-Adjusted Performance

12 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Kuang Chi Technologies are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Kuang Chi sustained solid returns over the last few months and may actually be approaching a breakup point.

Cabio Biotech Wuhan

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Cabio Biotech Wuhan has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Pair Trading with Kuang Chi and Cabio Biotech

The main advantage of trading using opposite Kuang Chi and Cabio Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Kuang Chi position performs unexpectedly, Cabio Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cabio Biotech will offset losses from the drop in Cabio Biotech's long position.

The idea behind Kuang Chi Technologies and Cabio Biotech Wuhan pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.